FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022226231> ?p ?o ?g. }

• W2022226231 endingPage "287" @default.
• W2022226231 startingPage "279" @default.
• W2022226231 abstract "Objective. To compare live birth rates in women with recurrent pregnancy loss (RPL) and either autoantibodies or a coagulation abnormality, treated with low molecular weight heparin plus aspirin (LMWH/ASA) or ASA alone, and to place our results in context with other randomized clinical trials (RCT) with similar cohorts. Methods. The HepASA Trial was an RCT including patients with a history of RPL and at least 1 of the following: antiphospholipid antibody (aPL), an inherited thrombophilia, or antinuclear antibody. Treatment groups were stratified by aPL status and history of early versus late pregnancy losses. Patients received either LMWH/ASA or ASA alone. The primary outcome was live birth; secondary outcomes included adverse events and bone loss at the spine and femoral neck. Literature over the past 20 years was reviewed to identify comparable RCT. Results. Over 4 years, 859 women with RPL were screened: 88 (10.2%) fulfilled inclusion criteria, became pregnant and were randomized to receive either LMWH/ASA or ASA alone. aPL were present in 42 (47.7%) patients in each group. The trial was stopped after 4 years when an interim analysis showed no difference in live birth rates in the 2 groups, and a lower rate of pregnancy loss in the ASA only group than expected. In the LMWH/ASA group, 35/45 (77.8%) had a live birth versus 34/43 (79.1%) in the ASA only group (p = 0.71). Neither number of prior losses nor aPL status was correlated with pregnancy outcome. There were no cases of pregnancy related thrombosis in either group. Mean change in BMD did not differ by treatment group at either the lumbar spine (p = 0.57) or femoral neck (p = 0.15). RCT since 2000 for aPL positive women with RPL and similar inclusion criteria report a mean live birth rate of 75% with either LMWH or ASA. Conclusion. LMWH/ASA did not confer incremental benefit compared to ASA alone for this population. Regardless of treatment regimen, number of prior losses, or aPL positivity, almost 80% of women in our RPL cohort had a successful pregnancy outcome. These findings contribute to a growing body of literature that contests the emerging standard of care comprising LMWH/ASA for this population." @default.
• W2022226231 created "2016-06-24" @default.
• W2022226231 creator A5010566326 @default.
• W2022226231 creator A5012476596 @default.
• W2022226231 creator A5032930756 @default.
• W2022226231 creator A5040813260 @default.
• W2022226231 creator A5050799596 @default.
• W2022226231 creator A5055721179 @default.
• W2022226231 creator A5060776202 @default.
• W2022226231 creator A5071835932 @default.
• W2022226231 creator A5079142034 @default.
• W2022226231 date "2009-02-01" @default.
• W2022226231 modified "2023-10-18" @default.
• W2022226231 title "Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial" @default.
• W2022226231 cites W1548346841 @default.
• W2022226231 cites W1964608845 @default.
• W2022226231 cites W1976108666 @default.
• W2022226231 cites W1987737906 @default.
• W2022226231 cites W1994709901 @default.
• W2022226231 cites W1998060814 @default.
• W2022226231 cites W2003410007 @default.
• W2022226231 cites W2004888846 @default.
• W2022226231 cites W2007748130 @default.
• W2022226231 cites W2013844042 @default.
• W2022226231 cites W2015663105 @default.
• W2022226231 cites W2016356045 @default.
• W2022226231 cites W2023684188 @default.
• W2022226231 cites W2027700387 @default.
• W2022226231 cites W2061071054 @default.
• W2022226231 cites W2062467631 @default.
• W2022226231 cites W2066657945 @default.
• W2022226231 cites W2082068268 @default.
• W2022226231 cites W2087168597 @default.
• W2022226231 cites W2106356304 @default.
• W2022226231 cites W2107201882 @default.
• W2022226231 cites W2107453274 @default.
• W2022226231 cites W2112422400 @default.
• W2022226231 cites W2126523771 @default.
• W2022226231 cites W2136152362 @default.
• W2022226231 cites W2146203649 @default.
• W2022226231 cites W2170555033 @default.
• W2022226231 cites W2233950919 @default.
• W2022226231 cites W2316710385 @default.
• W2022226231 cites W2320143189 @default.
• W2022226231 cites W2322561651 @default.
• W2022226231 cites W2469927335 @default.
• W2022226231 cites W83073700 @default.
• W2022226231 doi "https://doi.org/10.3899/jrheum.080763" @default.
• W2022226231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19208560" @default.
• W2022226231 hasPublicationYear "2009" @default.
• W2022226231 type Work @default.
• W2022226231 sameAs 2022226231 @default.
• W2022226231 citedByCount "307" @default.
• W2022226231 countsByYear W20222262312012 @default.
• W2022226231 countsByYear W20222262312013 @default.
• W2022226231 countsByYear W20222262312014 @default.
• W2022226231 countsByYear W20222262312015 @default.
• W2022226231 countsByYear W20222262312016 @default.
• W2022226231 countsByYear W20222262312017 @default.
• W2022226231 countsByYear W20222262312018 @default.
• W2022226231 countsByYear W20222262312019 @default.
• W2022226231 countsByYear W20222262312020 @default.
• W2022226231 countsByYear W20222262312021 @default.
• W2022226231 countsByYear W20222262312022 @default.
• W2022226231 countsByYear W20222262312023 @default.
• W2022226231 crossrefType "journal-article" @default.
• W2022226231 hasAuthorship W2022226231A5010566326 @default.
• W2022226231 hasAuthorship W2022226231A5012476596 @default.
• W2022226231 hasAuthorship W2022226231A5032930756 @default.
• W2022226231 hasAuthorship W2022226231A5040813260 @default.
• W2022226231 hasAuthorship W2022226231A5050799596 @default.
• W2022226231 hasAuthorship W2022226231A5055721179 @default.
• W2022226231 hasAuthorship W2022226231A5060776202 @default.
• W2022226231 hasAuthorship W2022226231A5071835932 @default.
• W2022226231 hasAuthorship W2022226231A5079142034 @default.
• W2022226231 hasBestOaLocation W20222262311 @default.
• W2022226231 hasConcept C126322002 @default.
• W2022226231 hasConcept C131872663 @default.
• W2022226231 hasConcept C141071460 @default.
• W2022226231 hasConcept C151730666 @default.
• W2022226231 hasConcept C168563851 @default.
• W2022226231 hasConcept C187212893 @default.
• W2022226231 hasConcept C2776874634 @default.
• W2022226231 hasConcept C2776884760 @default.
• W2022226231 hasConcept C2777557582 @default.
• W2022226231 hasConcept C2777628954 @default.
• W2022226231 hasConcept C2778279030 @default.
• W2022226231 hasConcept C2779234561 @default.
• W2022226231 hasConcept C2779343474 @default.
• W2022226231 hasConcept C2780842393 @default.
• W2022226231 hasConcept C2780868729 @default.
• W2022226231 hasConcept C2909731803 @default.
• W2022226231 hasConcept C46973012 @default.
• W2022226231 hasConcept C54355233 @default.
• W2022226231 hasConcept C61943457 @default.
• W2022226231 hasConcept C71924100 @default.
• W2022226231 hasConcept C86803240 @default.
• W2022226231 hasConceptScore W2022226231C126322002 @default.

• next